80
51
Growth Score
-5 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
397964
Medikine specializes in the creation of novel cytokine and growth factor receptor agonists.
Angie Park: VP ImmunologyPast Role: OncoMed Pharmaceuticals, Sr. Director Immunotherapy- Gianna M. Bosko: Chief Administrative Officer, General Counsel, and Secretary
About the Company
Medikine is a biotechnology company that specializes in the creation of novel cytokine and growth factor receptor agonists. Medikine’s proprietary compounds mimic the activities of the natural protein agonists, but are much lower in molecular weight and completely unrelated in sequence and structure.
It was founded in 2008 and headquartered in
Menlo Park, California.
